Literature DB >> 11703580

Pain management in polycystic kidney disease.

Z H Bajwa1, S Gupta, C A Warfield, T I Steinman.   

Abstract

Pain is a common complaint in patients with autosomal-dominant polycystic kidney disease, and a systematic approach is needed to differentiate the etiology of the pain and define an approach to management. A thorough history is the best clue to the multifactorial causes of the pain, superimposed upon an understanding of the complex innervation network that supplies the kidneys. The appropriate use of diagnostic radiology (especially MRI) will assist in differentiating the mechanical low back pain caused by cyst enlargement, cyst rupture and cyst infection. Also, the increased incidence of uric acid nephrolithiasis as a factor in producing renal colic must be considered when evaluating acute pain in the population at risk. MRI is not a good technique to detect renal calculi, a frequent cause of pain in polycystic kidney disease. If stone disease is a possibility, then abdominal CT scan and/or ultrasound should be the method of radiologic investigation. Pain management is generally not approached in a systematic way in clinical practice because most physicians lack training in the principles of pain management. The first impulse to give narcotics for pain relief must be avoided. Since chronic pain cannot be "cured," an approach must include techniques that allow the patient to adapt to chronic pain so as to limit interference with their life style. A detailed stepwise approach for acute and chronic pain strategies for the patient with autosomal dominant polycystic kidney disease is outlined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703580     DOI: 10.1046/j.1523-1755.2001.00985.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Acute abdomen and hemorrhagic shock caused by spontaneous rupture of renal cyst in autosomal dominant polycystic kidney disease.

Authors:  İsmail Yaman; İsmet Sağlam; Kamile Kurt
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

2.  Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.

Authors:  Eyüp Veli Küçük; Ahmet Tahra; Ahmet Bindayi; Ferhat Yakup Suçeken; Fikret Fatih Önol; Uğur Boylu
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 3.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

4.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 5.  Celiac plexus block in the management of chronic abdominal pain.

Authors:  Maunak V Rana; Kenneth D Candido; Omar Raja; Nebojsa Nick Knezevic
Journal:  Curr Pain Headache Rep       Date:  2014-02

Review 6.  Current management of autosomal dominant polycystic kidney disease.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2015-09-06

Review 7.  Autosomal dominant polycystic kidney disease and transplantation.

Authors:  Mariusz Niemczyk; Stanisław Niemczyk; Leszek Paczek
Journal:  Ann Transplant       Date:  2009 Oct-Dec       Impact factor: 1.530

8.  Laparoscopic nephrectomy for polycystic kidney: comparison of the transperitoneal and retroperitoneal approaches.

Authors:  Thibaut Benoit; Benoit Peyronnet; Mathieu Roumiguié; Grégory Verhoest; Jean-Baptiste Beauval; Arnaud Delreux; Dominique Chauveau; Bernard Malavaud; Andréa Manunta; Michel Soulié; Pascal Rischmann; Karim Bensalah; Xavier Gamé
Journal:  World J Urol       Date:  2015-12-10       Impact factor: 4.226

9.  Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results.

Authors:  See Hyung Kim; Seung Hyup Kim; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

10.  Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease.

Authors:  Young Rae Lee; Kyu-Beck Lee
Journal:  Korean J Radiol       Date:  2003 Oct-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.